Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor <scp>XMU‐MP‐1,</scp> protects the heart against adverse effects during pressure overload

Abstract

The Hippo pathway inhibitor, XMU-MP-1, reduced cellular hypertrophy and improved survival in cultured cardiomyocytes and, in vivo, preserved cardiac function following pressure overload.